Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details

Bulletin Express

Nov 07

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.

The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1120115825"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120115825\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120115825?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120115825","market":"hk","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-07 16:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1120115825","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120115825","pubTimestamp":1762503734,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"上海复星医药（集团）股份有限公司(02196)公布2025年第二次临时股东大会详情","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.\nThe meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}